Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

October 04, 2018

Reinmann v. TG Therapeutics, Inc. et al

Track this case

Case Number:

1:18-cv-09104

Court:

New York Southern

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Katherine Polk Failla

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 04, 2018

    Biopharma Co. Sued After Leukemia Treatment Trial Fails

    A TG Therapeutics Inc. stockholder filed a proposed class action in New York federal court on Thursday accusing the biopharmaceutical company of making optimistic statements about the clinical trial performance of two drugs used to treat leukemia despite knowing that the drug therapy had failed.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login